Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Clear-cell Renal Carcinoma”

539 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 539 results

Large-scale testing (Phase 3)Active Not RecruitingNCT04736706
What this trial is testing

Pembrolizumab (MK-3475) in Combination With Belzutifan (MK-6482) and Lenvatinib (MK-7902), or Pembrolizumab/Quavonlimab (MK-1308A) in Combination With Lenvatinib, Versus Pembrolizumab and Lenvatinib, for Treatment of Advanced Clear Cell Renal Cell Carcinoma (MK-6482-012)

Who this might be right for
Carcinoma, Renal Cell
Merck Sharp & Dohme LLC 1,854
Large-scale testing (Phase 3)Study completedNCT01120249
What this trial is testing

S0931, Everolimus in Treating Patients With Kidney Cancer Who Have Undergone Surgery

Who this might be right for
Kidney Cancer
SWOG Cancer Research Network 1,545
Not applicableEnded earlyNCT00727532
What this trial is testing

Sorafenib in Treating Patients With Locally Advanced or Metastatic Kidney Cancer

Who this might be right for
Hereditary Clear Cell Renal Cell CarcinomaKidney Cancer
Northwestern University 9
Post-approval studies (Phase 4)Ended earlyNCT02570789
What this trial is testing

Evaluation of Predictive Markers for Toxicity and Efficacy in Patients With mccRCC Treated by Anti-VEGF Therapy

Who this might be right for
Clear-cell Metastatic Renal Cell Carcinoma
Cliniques universitaires Saint-Luc- Université Catholique de Louvain 90
Early research (Phase 1)Study completedNCT00499135
What this trial is testing

Sunitinib Malate in Treating Patients With Unresectable or Metastatic Kidney Cancer or Other Advanced Solid Tumors

Who this might be right for
Adult Solid NeoplasmClear Cell Renal Cell CarcinomaRecurrent Renal Cell Carcinoma+2 more
National Cancer Institute (NCI) 25
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07691476
What this trial is testing

Multicenter Single-Arm Clinical Trial of Zanzalintinib and Pembrolizumab in Subjects With Resectable Clear Cell Renal Cell Carcinoma

Who this might be right for
Patients With Locally Advanced or Metastatic But Resectable Clear Cell Renal Cell Carcinoma
Yonsei University 48
Testing effectiveness (Phase 2)Ended earlyNCT00853125
What this trial is testing

Sunitinib and Irradiated Donor Lymphocytes in Treating Patients With Metastatic Kidney Cancer

Who this might be right for
Kidney Cancer
Rutgers, The State University of New Jersey 10
Testing effectiveness (Phase 2)UnknownNCT05172440
What this trial is testing

A Study on the Safety and Effectiveness of Tislelizumab Combined With Axitinib for Neoadjuvant Treatment of ccRCC

Who this might be right for
Neoadjuvant Therapy
Hongqian Guo 20
Testing effectiveness (Phase 2)Ended earlyNCT00318110
What this trial is testing

Matched Unrelated Donor Transplant for Metastatic Renal Cell Carcinoma

Who this might be right for
Metastatic Renal Cell Carcinoma
Center for International Blood and Marrow Transplant Research 4
Testing effectiveness (Phase 2)Looking for participantsNCT06302569
What this trial is testing

Pembrolizumab Plus Enfortumab Vedotin in Collecting Duct and Renal Medullary Carcinoma

Who this might be right for
Bellini CarcinomaCollecting Duct CarcinomaRenal Medullary Carcinoma
Giuseppe Procopio 23
Testing effectiveness (Phase 2)Study completedNCT02607553
What this trial is testing

Safety and Activity of G-202 in Patients With Clear Cell Renal Cell Carcinoma That Expresses PSMA

Who this might be right for
Clear Cell Renal Cell Carcinoma
GenSpera, Inc. 2
Testing effectiveness (Phase 2)UnknownNCT05024318
What this trial is testing

NeoAdjuvant Pembrolizumab and STEreotactic Radiotherapy Prior to Nephrectomy for Renal Cell Carcinoma

Who this might be right for
Renal Cell Carcinoma, Clear Cell, Somatic
Peter MacCallum Cancer Centre, Australia 20
Testing effectiveness (Phase 2)Study completedNCT00459979
What this trial is testing

Sunitinib in Treating Patients With Kidney Cancer That Cannot Be Removed by Surgery

Who this might be right for
Kidney Cancer
Case Comprehensive Cancer Center 30
Very early researchLooking for participantsNCT07067905
What this trial is testing

Clinical Evaluation of [68Ga]Ga-XT771 PET for Diagnosis in Patients With Glioblastoma and Clear Cell Renal Cell Carcinoma

Who this might be right for
Clear Cell Renal Cell Carcinoma and Glioblastoma
Chinese PLA General Hospital 15
Large-scale testing (Phase 3)Study completedNCT02883153
What this trial is testing

Zirconium-89-girentuximab PET/CT Imaging in Renal Cell Carcinoma

Who this might be right for
Renal Cell Carcinoma
Radboud University Medical Center 30
Testing effectiveness (Phase 2)Study completedNCT04704219
What this trial is testing

Pembrolizumab Plus Lenvatinib for First-line Advanced/Metastatic Non-clear Cell Renal Cell Carcinoma (1L nccRCC) (MK-3475-B61)

Who this might be right for
Renal Cell Carcinoma
Merck Sharp & Dohme LLC 160
Early research (Phase 1)Not Yet RecruitingNCT07770802
What this trial is testing

Clinical Study of HS-IT101 Injection in the Treatment of Advanced Renal Cancer

Who this might be right for
Clear Cell Renal Cell Carcinoma
Qingdao Sino-Cell Biomedicine Co., Ltd. 15
Very early researchStudy completedNCT04028245
What this trial is testing

Combination Spartalizumab and Canakinumab in Patients With Localized Clear Cell Renal Cell Carcinoma

Who this might be right for
Carcinoma, Renal Cell
Columbia University 17
Large-scale testing (Phase 3)Looking for participantsNCT07383441
What this trial is testing

Adding Biotherapy or Placebo to Standard Treatment for Advanced Kidney Cancer

Who this might be right for
Advanced Clear Cell Renal Cell CarcinomaMetastatic Clear Cell Renal Cell CarcinomaStage III Renal Cell Cancer AJCC v8+1 more
SWOG Cancer Research Network 718
Not applicableNot Yet RecruitingNCT07776483
What this trial is testing

Personalized ctDNA Monitoring for Predicting Immunotherapy Outcomes in Advanced Non-Clear Cell Renal Cell Carcinoma

Who this might be right for
Non-Clear Cell Renal Cell Carcinoma
West China Hospital 67
Next Page